BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12905777)

  • 41. Value of high resolution ultrasound and contrast enhanced US pulse inversion imaging for the evaluation of the vascular integrity of free-flap grafts.
    Prantl L; Pfister K; Kubale R; Schmitt S; Stockhammer V; Jung W; Zorger N; Herold T; Nerlich M; Stehr A; Jung EM
    Clin Hemorheol Microcirc; 2007; 36(3):203-16. PubMed ID: 17361023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparing Levovist-enhanced pulse inversion harmonic imaging and ferumoxides-enhanced MR imaging of hepatic metastases.
    Del Frate C; Zuiani C; Londero V; Como G; Bazzocchi M; Mortele K; Ros PR
    AJR Am J Roentgenol; 2003 May; 180(5):1339-46. PubMed ID: 12704048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultrasound contrast agents in radiological diagnosis.
    Burns PN
    Radiol Med; 1994 May; 87(5 Suppl 1):71-82. PubMed ID: 8209021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase-dependent dual-frequency contrast imaging at sub-harmonic frequency.
    Shen CC; Cheng CH; Yeh CK
    IEEE Trans Ultrason Ferroelectr Freq Control; 2011 Feb; 58(2):379-88. PubMed ID: 21342823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US.
    Jang HJ; Lim HK; Lee WJ; Kim SH; Kim MJ; Choi D; Lee SJ; Lim JH
    Korean J Radiol; 2003; 4(2):91-100. PubMed ID: 12845304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrasound contrast imaging research.
    Averkiou M; Powers J; Skyba D; Bruce M; Jensen S
    Ultrasound Q; 2003 Mar; 19(1):27-37. PubMed ID: 12970614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrasound contrast agents: an overview.
    Cosgrove D
    Eur J Radiol; 2006 Dec; 60(3):324-30. PubMed ID: 16938418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Contrast media in ultrasonography].
    Karstrup S; Juul NP
    Ugeskr Laeger; 1999 May; 161(20):2938-43. PubMed ID: 10354779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of malignant liver tumors: biphasic MS-CT versus quantitative contrast harmonic imaging ultrasound.
    Clevert DA; Jung EM; Stock KF; Weckbach S; Feuerbach S; Reiser M; Jung F
    Z Gastroenterol; 2009 Dec; 47(12):1195-202. PubMed ID: 19960397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrasound Imaging.
    Schmitz G; Dencks S
    Recent Results Cancer Res; 2020; 216():135-154. PubMed ID: 32594386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Onset delay of acoustic second harmonic backscatter from bubbles or microspheres.
    Zheng W; Newhouse VL
    Ultrasound Med Biol; 1998 May; 24(4):513-22. PubMed ID: 9651961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrasound properties of liver with and without particulate contrast agents.
    Tuthill TA; Baggs RB; Violante MR; Parker KJ
    Ultrasound Med Biol; 1991; 17(3):231-7. PubMed ID: 1887508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contrast agents in diagnostic ultrasound.
    Ophir J; Parker KJ
    Ultrasound Med Biol; 1989; 15(4):319-33. PubMed ID: 2669297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Principles and recent developments in ultrasound contrast agents.
    de Jong N; Ten Cate FJ; Lancée CT; Roelandt JR; Bom N
    Ultrasonics; 1991 Jul; 29(4):324-30. PubMed ID: 2058051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasound contrast agents: clinical applications.
    Jakobsen JA
    Eur Radiol; 2001; 11(8):1329-37. PubMed ID: 11519539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of polymeric microballoons as ultrasound contrast agents for liver imaging.
    Schneider M; Broillet A; Bussat P; Ventrone R
    Invest Radiol; 1994 Jun; 29 Suppl 2():S149-51. PubMed ID: 7928213
    [No Abstract]   [Full Text] [Related]  

  • 57. A perfusion phantom for the evaluation of ultrasound contrast agents.
    Hindle AJ; Perkins AC
    Ultrasound Med Biol; 1994; 20(3):309-14. PubMed ID: 8059492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomolecular Ultrasound Imaging of Phagolysosomal Function.
    Ling B; Lee J; Maresca D; Lee-Gosselin A; Malounda D; Swift MB; Shapiro MG
    ACS Nano; 2020 Sep; 14(9):12210-12221. PubMed ID: 32902951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Particle-stabilized bubbles for enhanced organ ultrasound imaging.
    Violante MR; Baggs RB; Tuthill T; Dentinger P; Parker KJ
    Invest Radiol; 1991 Nov; 26 Suppl 1():S194-7; discussion S198-200. PubMed ID: 1808127
    [No Abstract]   [Full Text] [Related]  

  • 60. A review of physical phenomena associated with ultrasonic contrast agents and illustrative clinical applications.
    Deng CX; Lizzi FL
    Ultrasound Med Biol; 2002 Mar; 28(3):277-86. PubMed ID: 11978407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.